TCS, HDFCBANK, SBI Liquid Fund (G)
Orchid Pharma Ltd.
Orchid Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 22 05 2021 | Audited Results |
| 15 07 2021 | inter-alia, to consider and approve: Fund raising by way of issuance of equity shares through preferential allotment/private placement in single/multiple tranches. |
| 13 08 2021 | Quarterly Results |
| 14 11 2021 | Quarterly Results |
| 12 02 2022 | Quarterly Results |
| 12 05 2022 | Audited Results |
| 10 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 01 12 2022 | Inter alia, to consider and approve, amongst other things, raising of funds and issuance of securities through Qualified Institutions Placement basis or through any other permissible mode, in one or more tranches, subject to applicable laws and necessary approval from the shareholders and other regulatory authorities, as may be required. |
| 09 02 2023 | Quarterly Results |
| 10 05 2023 | Audited Results |
| 10 08 2023 | Quarterly Results |
| 04 11 2023 | Quarterly Results |
| 08 02 2024 | Quarterly Results |
| 11 11 2024 | Quarterly Results |
| 12 02 2025 | Quarterly Results |
News
No News data available
